Thanks to high-throughput NGS studies in patients with CML, two novel polymorphisms, rs460089 and rs2631365, have been described as OCTN1 and OCTN2 promoters, respectively. The gene discussed is SLC22A4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.